ClinicalTrials.gg
Drug

Insulin degludec clinical trials

Also written Tresiba and NN1250.

studies test it
128
open now
6
in phase 3
59
first study started
2006

How each study uses insulin degludec is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the insulin degludec studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
25 Sept 2015 · RYZODEG 70/30 · BLA 203313 (FDA, Drugs@FDA; in a combination)
European Union
20 Jan 2013 · Tresiba · EMEA/H/C/002498 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

insulin degludec
70
Degludec
6

Brand

Tresiba
7

Development codes

NN1250
2

In one entry with another drug

Given together, or one or the other

insulin degludec/insulin aspart
30
insulin degludec/liraglutide
20
IDegAsp
4
Insulin Degludec and Insulin Aspart
2
Insulin Degludec and Insulin Aspart Injection
2

Studies by the year they started

128 studies that test it; most in 2010 (23)

Studies that test insulin degludec, by start year
YearStudies
20063
20071
20084
200916
201023
201111
201211
201310
20144
20154
20167
20179
20188
20191
20215
20223
20234
20242
20251
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
46
Phase 2
3
Phase 3
59
Phase 4
15
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 107 · Other 21

Novo Nordisk A/S (99) · Mannkind Corporation (2) · Ain Shams University (2) · Tonghua Dongbao Pharmaceutical Co.,Ltd (2) · Sunshine Lake Pharma Co., Ltd. (1) · Beijing Hospital (1) · Medanta, The Medicity, India (1) · University of Palermo (1)

Often tested with

Tested in the same studies.

Insulin Aspart (18) · Liraglutide (18) · Insulin Glargine (17) · Insulin aspart, insulin aspart protamine drug combination 30:70 (3) · Insulin, Regular, Human (2) · Insulin icodec (1) · Insulin Lispro (1) · Insulin glulisine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Insulin degludec is the comparator. A study of two new drugs counts under both.

  • 1SHR-3167 · Jiangsu HengRui Medicine Co., Ltd. · next primary completion Jan 2028
  • 1GZR33 · Gan & Lee Pharmaceuticals.
Reaching primary completion within a year · 1

Studies that test insulin degludec.

Studies

Open first, then newest update. How each study uses insulin degludec is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 128

See all 128 studies that test insulin degludec →

Given beside what is tested · 27 — insulin degludec is usual care or a partner of the new treatment

Showing 20 of 27.

As the comparator · 34 — what is tested is compared with insulin degludec

Showing 20 of 34.

Codes

What other systems call insulin degludec · ClinicalTrials.gg INT006051

  • MeSH (NLM) C571886insulin degludecConfirmed NLM, Wikidata
  • UNII (FDA) 54Q18076QBINSULIN DEGLUDECConfirmed FDA, NLM, Wikidata
  • RxNorm 1670007Confirmed FDA, Wikidata
  • Wikidata Q16252338Insulin degludecConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C142979Insulin DegludecOne source FDA
  • DrugBank DB09564One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.